Genmab A/S (OTCMKTS:GNMSF) Share Price Crosses Above 50-Day Moving Average – Here’s Why

Genmab A/S (OTCMKTS:GNMSF)’s share price crossed above its 50-day moving average during trading on Tuesday . The stock has a 50-day moving average of $222.02 and traded as high as $249.25. Genmab A/S shares last traded at $249.25, with a volume of 131 shares traded.

Genmab A/S Stock Performance

The company has a market cap of $16.47 billion, a PE ratio of 12.51 and a beta of 0.90. The stock’s 50-day simple moving average is $222.02 and its 200 day simple moving average is $211.38.

Genmab A/S (OTCMKTS:GNMSF) last issued its earnings results on Thursday, August 7th. The company reported $5.42 earnings per share for the quarter, beating the consensus estimate of $3.99 by $1.43. The business had revenue of $925.00 million for the quarter, compared to the consensus estimate of $949.06 million. Genmab A/S had a net margin of 37.53% and a return on equity of 21.03%.

Genmab A/S Company Profile

Genmab A/S develops antibody therapeutics for the treatment of cancer and other diseases primarily in Denmark. The company markets DARZALEX, a human monoclonal antibody for the treatment of patients with multiple myeloma (MM); teprotumumab for the treatment of thyroid eye disease; and Amivantamab for advanced or metastatic gastric or esophageal cancer and NSCLC.